Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H C Tan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of the Academy of Medicine, Singapore|November 13, 2004
Stem cells: current usage and future potentialsP H C Tan
Annals of the Academy of Medicine, Singapore|January 11, 2003
High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myelomaL P Koh, Y C Linn, G Teoh, et al.
American Journal of Hematology|November 26, 2002
Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantationL P Koh, A Kurup, Y T Goh, et al.
Singapore Medical Journal|May 15, 2004
Therapeutic plasmapheresis for the treatment of the thrombotic thrombocytopenic purpura-haemolytic uraemic syndromesW Y K Hwang, L Y A Chai, H J Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabineL P Koh, M B C Koh, H Y Ng, et al.
Clinical Genetics|October 7, 2005
Evidence for deletion of 9q as a two-step process in chronic myeloid leukemiaC Rudduck-Sivaswaren, S-L Tien, P Lim, et al.
Bone Marrow Transplantation|March 7, 2003
Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisisL P Koh, W Y K Hwang, C T H Chuah, et al.
Annals of Hematology|April 3, 2004
Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefitsL P Koh, W Y K Hwang, C H Tan, et al.
Bone Marrow Transplantation|June 23, 2004
A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantationW Y K Hwang, L-P Koh, H J Ng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2003
MARS therapy in critically ill patients with advanced malignancy: a clinical and technical reportH K Tan, J S S Lim, C K Tan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of the Academy of Medicine, Singapore|November 13, 2004
Stem cells: current usage and future potentialsP H C Tan
Annals of the Academy of Medicine, Singapore|January 11, 2003
High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myelomaL P Koh, Y C Linn, G Teoh, et al.
American Journal of Hematology|November 26, 2002
Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantationL P Koh, A Kurup, Y T Goh, et al.
Singapore Medical Journal|May 15, 2004
Therapeutic plasmapheresis for the treatment of the thrombotic thrombocytopenic purpura-haemolytic uraemic syndromesW Y K Hwang, L Y A Chai, H J Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabineL P Koh, M B C Koh, H Y Ng, et al.
Clinical Genetics|October 7, 2005
Evidence for deletion of 9q as a two-step process in chronic myeloid leukemiaC Rudduck-Sivaswaren, S-L Tien, P Lim, et al.
Bone Marrow Transplantation|March 7, 2003
Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisisL P Koh, W Y K Hwang, C T H Chuah, et al.
Annals of Hematology|April 3, 2004
Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefitsL P Koh, W Y K Hwang, C H Tan, et al.
Bone Marrow Transplantation|June 23, 2004
A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantationW Y K Hwang, L-P Koh, H J Ng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2003
MARS therapy in critically ill patients with advanced malignancy: a clinical and technical reportH K Tan, J S S Lim, C K Tan, et al.
Pageof 1